Leading reasons for exclusion were prior use of U-500 regular insulin; baseline A1C not in range or out of time window; no follow-up A1C available within 6 months; type 1 diabetes; and V-Go not initiated. The gene discussed is INS; the disease is type 1 diabetes mellitus.